Latest Breaking News On - Silence therapeutics - Page 4 : comparemela.com

Silence Therapeutics (SLN) Announces Retirement of Alistair Gray from Board of Directors

Silence Therapeutics (SLN) Announces Retirement of Alistair Gray from Board of Directors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesCity ofUnited kingdomIain rossAlistair grayCraig toomanSilence therapeuticsSilence boardSenior independentChief executive officer

Morgan Stanley Reiterates Overweight Rating for Silence Therapeutics (NASDAQ:SLN)

Morgan Stanley Reiterates Overweight Rating for Silence Therapeutics (NASDAQ:SLN)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Parkman healthcare partnersVivo capitalMorgan stanleySg americas securitiesSilence therapeuticsFree reportTherapeutics trading downGet free reportHealthcare partnersOligonucleotide discoverySilence therapeutics daily

Silence Therapeutics (LON:SLN) Stock Price Crosses Below 200 Day Moving Average of $535 00

Silence Therapeutics plc (LON:SLN – Get Free Report) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 535 ($6.66) and traded as low as GBX 512 ($6.37). Silence Therapeutics shares last traded at GBX 535 ($6.66), with a volume of 913,528 shares trading hands. […]

Silence therapeuticsGet free reportOligonucleotide discoverySilence therapeutics dailyLon sln

Short Interest in Silence Therapeutics plc (NASDAQ:SLN) Rises By 74 8%

Silence Therapeutics plc (NASDAQ:SLN – Get Free Report) was the recipient of a large increase in short interest in March. As of March 31st, there was short interest totalling 162,000 shares, an increase of 74.8% from the March 15th total of 92,700 shares. Based on an average trading volume of 241,700 shares, the short-interest ratio […]

Parkman healthcare partnersGoldman sachs group incSilence therapeutics company profileMorgan stanleyVivo capitalSilence therapeuticsGet free reportSachs groupHealthcare partnersTherapeutics trading downOligonucleotide discoverySilence therapeutics dailyNasdaq sln

3 Biotech Stocks to Turn $5,000 Into $1 Million: April 2024

Biotech stocks can offer some of the most explosive, exciting opportunities on the market.That is, if you find the right one.

Vipin gargMorgan stanleyDrug administrationFortress biotechJourney medicalNew drug applicationPrescription drug user fee actPriority review vouchersSilence therapeuticsChardan capital